Trial Profile
A retrospective study comparing survival outcomes with non-platinum (nab-paclitaxel, irinotecan) versus platinum based chemotherapy in patients with ERCC1 high locally advanced esophageal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Irinotecan
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 03 Apr 2017 New trial record